The Food and Drug Administration did not adequately address the potential risks of bisphenol A when assessing its safety, an independent panel of scientific experts has said.
Earlier this year, the FDA released a statement assuring Americans that the controversial chemical – used in plastic packaging and bottles – was safe at low levels, even for babies and children.
However, the panel of scientific experts has determined that the group’s judgment was flawed and did not take into account a number of studies that found evidence suggesting BPA was harmful.
For example, research conducted by the National Toxicology Program – part of the U.S. Department of Health and Human Services – suggested that BPA could pose a risk to children.
"The margins of safety defined by FDA as ‘adequate’ are, in fact, inadequate," the report stated, according to the Association Press.
In a statement, the FDA said it was "moving forward" with a plan to conduct additional research into BPA, adding that it would "carefully evaluate the findings of these studies."
Earlier this month, Canada became the first country to ban BPA from baby bottles. Commenting on the decision, the FDA said it was made due to an "abundance of caution."